Epoetin beta

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Epoetin beta
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
ATC code B03XA01 (WHO)
ChemSpider none
UNII 64FS3BFH5W N
 NYesY (what is this?)  (verify)

Epoetin beta (rINN) /ɛˈp.tn/ is a synthetic, recombinant[1] form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.

Epoetin is marketed under the trade names NeoRecormon.[2]

References[edit]

  1. ^ Dunn CJ, Markham A (1996). "Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure". Drugs. 51 (2): 299–318. doi:10.2165/00003495-199651020-00008. PMID 8808169. 
  2. ^ Amgen - Products. URL: http://www.amgen.com/patients/prca.html. Accessed on: October 21, 2007.

External links[edit]